Report overview
This report contains market size and forecasts of Gynecological Cancer Diagnostics in Global, including the following market information:
Global Gynecological Cancer Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Gynecological Cancer Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Genetic Counseling Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gynecological Cancer Diagnostics include UT Southwestern, Abramson Cancer Center, Northwestern Medicine, Sysmex Europe SE, Fujirebio, Premier Health, Agilent Technologies, Inc, ARUP Laboratories and CENTOGENE, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gynecological Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gynecological Cancer Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Gynecological Cancer Diagnostics Market Segment Percentages, by Type, 2021 (%)
Genetic Counseling Test
Cancer Risk Test
Kits Test
Global Gynecological Cancer Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Gynecological Cancer Diagnostics Market Segment Percentages, by Application, 2021 (%)
Gestational Trophoblastic Disease Diagnostics
Endometrial Cancer Diagnostics
Peritoneal Cancer Diagnostics
Cervical Cancer Diagnostics
Ovarian Cancer Diagnostics
Vaginal Cancer Diagnostics
Uterine Cancer Diagnostics
Vulvar Cancer Diagnostics
Global Gynecological Cancer Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Gynecological Cancer Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gynecological Cancer Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Gynecological Cancer Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
UT Southwestern
Abramson Cancer Center
Northwestern Medicine
Sysmex Europe SE
Fujirebio
Premier Health
Agilent Technologies, Inc
ARUP Laboratories
CENTOGENE
F. Hoffmann-La Roche Ltd
Fulgent Genetics, Inc
Invitae Corporation
Myriad Genetics, Inc
BGI Group
